# Effects of Atomoxetine on Cognitive Function in Schizophrenia

> **NCT00420498** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 12 (actual)

## Conditions studied

- Schizophrenia
- Cognition
- Smoking

## Interventions

- **DRUG:** Atomoxetine (Strattera™)

## Key facts

- **NCT ID:** NCT00420498
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2007-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420498, "Effects of Atomoxetine on Cognitive Function in Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00420498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*